Two Drug Industry Lawsuits Challenge West Virginia’s 340B Contract Pharmacy Access Law

PhRMA and Novartis each challenged West Virginia's new 340B contract pharmacy access law in a federal district court.
An influential drug industry group and a major drugmaker each filed lawsuits challenging West Virginia’s 340B contract pharmacy access law [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

News Alert

PhRMA Sues Mississippi Over New 340B Contract Pharmacy Law

The leading drugmaker advocacy group filed a legal challenge to Mississippi's recently enacted 340B contract pharmacy law
Mississippi this week became the fourth state to face a legal challenge to its 340B contract pharmacy law, when the [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

Novartis Asks Federal Court to Block New Maryland 340B Contract Pharmacy Law

Drugmaker Novartis filed suit to block Maryland's recently signed 340B contract pharmacy statute.
Maryland this week became the third state with a 340B contract pharmacy protection law to face a drugmaker lawsuit when [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

Appeals Court Contract Pharmacy Restrictions Decision Leaves Unanswered Questions, Ups Pressure for Legislative Action

The D.C. Circuit decided that two drugmakers' current contract pharmacy restrictions were legal, but it left open the possibility that more onerous restrictions may not be.
A federal appeals court’s decision this week to uphold two drugmakers’ 340B contract pharmacy restrictions left unanswered questions about the [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

Breaking News

Appeals Court Approves Drugmakers’ Federal 340B Contract Pharmacy Restrictions But Leaves Open Possibility of Enforcement Against Stricter Policies

A federal appeals court decided that the 340B statute does not prohibit all types of restrictions on 340B contract pharmacy use.
A federal appeals court today decided that the 340B statute does not prohibit drugmakers from placing conditions on the distribution [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

Federal Court Sets April 2025 Trial for AstraZeneca’s Arkansas 340B Law Challenge Amid State Enforcement Actions

The trial for drugmaker AstraZeneca's lawsuit against Arkansas' 340B contract pharmacy access law will take place in April 2025.
A federal judge scheduled an April 2025 trial date for AstraZeneca’s lawsuit against Arkansas’ 340B contract pharmacy access law as [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

Health System Appeal of False Claims Suit Against Drugmakers For Alleged 340B Overcharges Allowed to Move Forward

California-based health system Adventist Health System/West's lawsuit alleging drugmaker 340B overcharges was allowed to move forward in a federal appeals court.
A California health system’s lawsuit alleging “hundreds of millions” in overcharges by four drugmakers was recently released from required mediation [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

Pfizer Exempts Arkansas Hospitals from All Contract Pharmacy Restrictions

Pfizer is one of more than 20 drugmakers to fully or partially exempt Arkansas providers from its 340B contract pharmacy restrictions.
Pharmaceutical giant Pfizer announced it exempted Arkansas hospitals from its 340B contract pharmacy restrictions beginning this week. Effective May 6, [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

Appeals Court Rejects PhRMA’s Request for a Full Panel Rehearing of Arkansas 340B Contract Pharmacy Case

The U.S. 8th Circuit Court of Appeals denied PhRMA's request to reconsider a decision upholding Arkansas' 340B law.
A federal appeals court today rejected a drug industry trade group’s request for all of its appellate judges to reconsider [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

Louisiana AG, Health Centers Defend 340B Contract Pharmacy Law in Response to Drugmaker Suit

Louisiana Attorney General Liz Murrill (R) and a state provider group each filed response briefs to drugmaker AbbVie in a case challenging Louisiana's 340B contract pharmacy access law.
Louisiana Attorney General Liz Murrill (R) and a state provider group each filed response briefs to drugmaker AbbVie in a case challenging Louisiana's 340B contract pharmacy access law.
Louisiana’s 340B contract pharmacy access law is constitutional because it governs drug distribution and not pricing, a state official and [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »
×

*Sign up for news summaries and alerts from 340B Report

Site Footer Live